| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation and tyrosine kinase inhibitors: development and validation of a clinical prediction model based on cytogenetics, IKZF1 deletions and minimal residual disease
|
Zheng, Jing
|
|
|
104 |
3 |
p. 1867-1876
|
article
|
| 2 |
Antibiotic lock therapy for the treatment of peripherally inserted central venous catheter-related bloodstream infection in patients with hematological malignancies: a single center retrospective study
|
Zhang, Qin
|
|
|
104 |
3 |
p. 1975-1984
|
article
|
| 3 |
Anti-CD20 maintenance strategies to face the challenge of COVID-19 pandemic in follicular lymphoma: results from the R-FolSTOP multicentre Italian study
|
Castellino, Alessia
|
|
|
104 |
3 |
p. 1655-1667
|
article
|
| 4 |
A phase 1 study of durvalumab as monotherapy or combined with tremelimumab with or without azacitidine in patients with myelodysplastic syndrome
|
Garcia-Manero, Guillermo
|
|
|
104 |
3 |
p. 1577-1585
|
article
|
| 5 |
A predictive diagnostic model for refractory diffuse large B-cell lymphoma: a single-center retrospective cohort study
|
Lin, Yun
|
|
|
104 |
3 |
p. 1697-1704
|
article
|
| 6 |
A randomized controlled trial of conventional GVHD prophylaxis with or without teprenone for the prevention of severe acute GVHD
|
Kitamura, Wataru
|
|
|
104 |
3 |
p. 1917-1929
|
article
|
| 7 |
Assessment of anemia recovery using peripheral blood smears by deep semi-supervised learning
|
Yan, Qianming
|
|
|
104 |
3 |
p. 1527-1539
|
article
|
| 8 |
Association between HLA-DRB1*04, HLA-DQB1*03, and HLA-DQB1*06 with alloimmunization in transfusion-dependent patients with thalassemia: the first case-control study in Iran
|
Kargar, Masoud
|
|
|
104 |
3 |
p. 1493-1499
|
article
|
| 9 |
Azacitidine in combination with HAG for newly diagnosed and relapsed/refractory AML: a prospective cohort study
|
Pan, Hong
|
|
|
104 |
3 |
p. 1597-1604
|
article
|
| 10 |
Biomarkers in clonal haematopoiesis of indeterminate potential (CHIP) linking cardiovascular diseases, myeloid neoplasms and inflammation
|
Tan, Hui Shan Valerie
|
|
|
104 |
3 |
p. 1355-1366
|
article
|
| 11 |
Building a new score system for the diagnosis and differential diagnosis of typical CLL/SLL, atypical CLL/SLL, and MCL based on the flow cytometry immunophenotyping
|
Niyonizeye, Emile
|
|
|
104 |
3 |
p. 1807-1819
|
article
|
| 12 |
Challenges in managing iTTP: insights into ADAMTS13 inhibitor boosting during caplacizumab therapy
|
Tanaka, Haruyuki
|
|
|
104 |
3 |
p. 1507-1514
|
article
|
| 13 |
Combined heterozygosity for hemoglobin Paksé, α-thalassemia and for hemoglobin E, β- thalassemia ̵ first appearance in Europe
|
Schnedl, Wolfgang J.
|
|
|
104 |
3 |
p. 2059-2064
|
article
|
| 14 |
Comparative efficacy of venetoclax-based regiments in the management of chronic lymphocytic leukemia: a systematic review and metanalysis
|
Jamil, Abdur
|
|
|
104 |
3 |
p. 1387-1397
|
article
|
| 15 |
Comparison of ATG-thymoglobulin with atg-fresenius in patients with hematological malignancies who undergo allogeneic hematopoietic stem cell transplantation: a propensity score-matched analysis
|
Zhang, Hanyue
|
|
|
104 |
3 |
p. 1907-1916
|
article
|
| 16 |
Contribution of molecular characterization to the diagnosis of MPN in patients with low JAK2V617F variant allelic fraction in a real-world cohort
|
Lebecque, Benjamin
|
|
|
104 |
3 |
p. 1587-1596
|
article
|
| 17 |
Copy number alterations in pediatric B-cell precursor acute lymphoblastic leukemia patients and their association with patients’ outcome
|
Abdelfattah, Nesma E.
|
|
|
104 |
3 |
p. 1821-1832
|
article
|
| 18 |
Correction to: Delphi consensus recommendations on treatment for advanced-stage marginal zone lymphoma in South Korea
|
Kim, Seok Jin
|
|
|
104 |
3 |
p. 2081
|
article
|
| 19 |
Correction to: Evolution of frontline treatment for multiple myeloma: clinical investigation of quadruplets containing carflzomib and antiCD38 monoclonal antibodies
|
Costa, Luciano J.
|
|
|
104 |
3 |
p. 1353
|
article
|
| 20 |
CXCL9 and IL-18: potential biomarkers for efficacy evaluation in refractory hemophagocytic lymphohistiocytosis treated with RED (ruxolitinib, emapalumab and dexamethasone)
|
Lan, Xuan
|
|
|
104 |
3 |
p. 1459-1469
|
article
|
| 21 |
Effect of major ABO blood group mismatched HSCT on blood transfusion and clinical outcomes in AA patients
|
Lai, Dongdi
|
|
|
104 |
3 |
p. 1931-1947
|
article
|
| 22 |
Effect of POD24 on the prognosis of follicular and other indolent B-cell non-hodgkin lymphomas
|
Li, Xiaoyan
|
|
|
104 |
3 |
p. 1427-1442
|
article
|
| 23 |
Efficacy and mechanism of the XPO1 inhibitor selinexor combined with decitabine in T-cell lymphoblastic lymphoma
|
Meng, Miaomiao
|
|
|
104 |
3 |
p. 1747-1756
|
article
|
| 24 |
Efficacy of venetoclax combined with homoharringtonine and cytarabine for younger adults with newly diagnosed AML
|
Song, Bao-Quan
|
|
|
104 |
3 |
p. 1617-1622
|
article
|
| 25 |
Epcoritamab-Induced fatal pleural effusion in diffuse large B-Cell lymphoma: a case report and literature review
|
Takahata, Atsushi
|
|
|
104 |
3 |
p. 1995-2000
|
article
|
| 26 |
Epidemiological and clinical characteristics of children and young adults with Glanzmann’s thrombasthenia in upper Egypt: a multicenter cross-sectional study
|
Khalifa, Gehan Lotfy Abdel Hakeem
|
|
|
104 |
3 |
p. 1961-1973
|
article
|
| 27 |
Evolution of frontline treatment for multiple myeloma: clinical investigation of quadruplets containing carfilzomib and anti-CD38 monoclonal antibodies
|
Costa, Luciano J.
|
|
|
104 |
3 |
p. 1329-1351
|
article
|
| 28 |
Exploring perceptions in the management and treatment of polycythaemia vera in the UK
|
Bagnall, Becky
|
|
|
104 |
3 |
p. 1623-1631
|
article
|
| 29 |
Fertility assessment in long-term young female survivors with hematological disease after allogeneic hematopoietic cell transplantation: a single-center real-life cross-sectional study
|
Hou, Yanru
|
|
|
104 |
3 |
p. 1897-1905
|
article
|
| 30 |
Further strategies after immune checkpoint inhibitors in relapsed/refractory Hodgkin lymphoma: salvage treatments and consolidation with transplantation, experience in daily clinical practice
|
Pellegrini, Cinzia
|
|
|
104 |
3 |
p. 1757-1764
|
article
|
| 31 |
Gain or amplification of 1q21 in systemic light chain amyloidosis is associated with advanced Mayo stage, plasma cell disease and worse overall survival
|
Oubari, Sara
|
|
|
104 |
3 |
p. 1777-1788
|
article
|
| 32 |
Genetic alterations and their prognostic impact in marginal zone lymphoma: a meta-analysis
|
Li, Xijing
|
|
|
104 |
3 |
p. 1307-1315
|
article
|
| 33 |
Genetic variants in NHEJ1 and related DNA repair disorders: insights into phenotypic heterogeneity and links to hypoplastic myelodysplastic syndromes and familial hematological malignancies susceptibility
|
Elbadry, Mahmoud I.
|
|
|
104 |
3 |
p. 1633-1653
|
article
|
| 34 |
Gilteritinib versus salvage chemotherapy in predominantly Asian patients with relapsed/refractory FLT3-mutated acute myeloid leukemia: a regional analysis of COMMODORE in China, South-East Asia, and Russia
|
Jiang, Bin
|
|
|
104 |
3 |
p. 1563-1575
|
article
|
| 35 |
Global, regional and national temporal trends in incidence and mortality of non-Hodgkin lymphoma from 1992 to 2021: an age-period-cohort analysis
|
Tang, Shanshan
|
|
|
104 |
3 |
p. 1679-1696
|
article
|
| 36 |
Hematopoietic stem cell transplantation and immunosuppressive therapy: implications of clonal haematopoiesis
|
Tan, Zhengwei
|
|
|
104 |
3 |
p. 1877-1886
|
article
|
| 37 |
Improved survival in older patients with myeloid malignancies undergoing haploidentical peripheral blood stem cell transplantation with low-dose anti-thymocyte globin (ATG)/post-cyclophosphamide (PTCy)-based regimen for graft-versus-host disease prophylaxis
|
Jia, Yannan
|
|
|
104 |
3 |
p. 1857-1866
|
article
|
| 38 |
Is there still a place for autologous salvage transplantation in relapsed/refractory multiple myeloma in the era of novel therapies?
|
Karp, Simone
|
|
|
104 |
3 |
p. 1735-1745
|
article
|
| 39 |
Low levels of CD3 + and CD8 + T cells in peripheral blood can predict poor efficacy of first-line chemotherapy in patients with angioimmunoblastic T cell lymphoma
|
Liu, Yanfei
|
|
|
104 |
3 |
p. 1705-1712
|
article
|
| 40 |
Metabolomics and machine learning approaches for diagnostic biomarkers screening in systemic light chain amyloidosis
|
Xie, Weiwei
|
|
|
104 |
3 |
p. 1669-1678
|
article
|
| 41 |
Mixed-phenotype leukemia with TCF3::ZNF384 fusion presenting as an isolated mediastinal mass
|
Au, Wing-Yan
|
|
|
104 |
3 |
p. 2023-2025
|
article
|
| 42 |
Molecular profiling of cell-free DNA from classic Hodgkin lymphoma patients identifies potential prognostic clusters and corresponds with disease dynamics
|
Veltmaat, Nick
|
|
|
104 |
3 |
p. 1789-1800
|
article
|
| 43 |
Mutational heterogeneities in STAT3 and clonal hematopoiesis-related genes in acquired pure red cell aplasia
|
Kawakami, Toru
|
|
|
104 |
3 |
p. 1471-1479
|
article
|
| 44 |
Novel AK-1 gene variants combined with thalassemia causing rare hereditary non-spherocytic hemolytic anemia in a Chinese family
|
Chen, Lizhu
|
|
|
104 |
3 |
p. 2035-2043
|
article
|
| 45 |
Novel ETV6::RAPGEF6 fusion gene in chronic eosinophilic leukemia: compiling evidence on the role of IL3 overexpression in tumorigenesis
|
Iberti, Mathilde
|
|
|
104 |
3 |
p. 2017-2021
|
article
|
| 46 |
Overview of 1q abnormalities in multiple myeloma: scientific opinions from Italian experts
|
D’Agostino, Mattia
|
|
|
104 |
3 |
p. 1443-1458
|
article
|
| 47 |
Polatuzumab vedotin and bendamustine (Pola-B) was effective for refractory CD20-negative double-expressor lymphoma
|
Ogasawara, Midori
|
|
|
104 |
3 |
p. 2075-2077
|
article
|
| 48 |
Post-transplant cyclophosphamide versus anti-thymocyte globulin in haploidentical stem cell transplantation: a systematic review and meta-analysis
|
Jin, Xuelian
|
|
|
104 |
3 |
p. 1317-1328
|
article
|
| 49 |
Racial disparities in cardiovascular manifestations among patients with sickle cell trait: analysis of national inpatient sample data (2016–2020)
|
Keesari, Praneeth Reddy
|
|
|
104 |
3 |
p. 1501-1506
|
article
|
| 50 |
Rapid detection of genetic modifiers of β-thalassemia based on MALDI-TOF MS
|
Huang, Li
|
|
|
104 |
3 |
p. 1481-1492
|
article
|
| 51 |
Rare case of pure red cell aplasia secondary to smoldering multiple myeloma successfully treated with daratumumab – case report and review of the literature
|
Alharbi, Malak
|
|
|
104 |
3 |
p. 2027-2034
|
article
|
| 52 |
Real-world data of siltuximab for Chinese patients with iMCD: combination with BCD regimen as a potential approach for severe cases
|
Li, Si-yuan
|
|
|
104 |
3 |
p. 1713-1720
|
article
|
| 53 |
Sequential combined bypassing therapy in haemophilia patients with high titer inhibitors: surgical experience
|
Ding, Bingjie
|
|
|
104 |
3 |
p. 1949-1960
|
article
|
| 54 |
Sickle cell disease and opioid overdose outcomes in the United States: a nationwide analysis
|
Bode, Anna L.
|
|
|
104 |
3 |
p. 1551-1561
|
article
|
| 55 |
Significance of targeting DNMT3A mutations in AML
|
Huang, Guiqin
|
|
|
104 |
3 |
p. 1399-1414
|
article
|
| 56 |
Successful sequential application of CAR T-cell-therapies in relapsed refractory multiple myeloma
|
Mobascher, Paul
|
|
|
104 |
3 |
p. 2055-2058
|
article
|
| 57 |
Sustained treatment-free remission in two chronic myeloid leukemia patients after asciminib discontinuation: a report of two cases
|
Yousefi, Arjen
|
|
|
104 |
3 |
p. 2065-2068
|
article
|
| 58 |
Targeting refractory diffuse large B cell lymphoma by CAR-WEE1 T-cells: In vitro evaluation
|
Ahmed, Hadeer Mohamed
|
|
|
104 |
3 |
p. 1833-1844
|
article
|
| 59 |
The efficacy of immunosuppressive therapy with or without thrombopoietin receptor agonist in elderly patients with severe aplastic anemia
|
Li, Jianping
|
|
|
104 |
3 |
p. 1515-1525
|
article
|
| 60 |
The impact of obesity and its related underlying diseases on cytokine release syndrome and the efficacy of CAR-T therapy in treating B-cell malignancies
|
Du, Mengyi
|
|
|
104 |
3 |
p. 1887-1895
|
article
|
| 61 |
The impact of various types of α-thalassemia on perinatal complications and pregnancy outcomes in pregnant women
|
Li, Yi
|
|
|
104 |
3 |
p. 1541-1550
|
article
|
| 62 |
The mutational landscape and its longitudinal dynamics in relapsed and refractory classic Hodgkin lymphoma
|
Witte, Hanno
|
|
|
104 |
3 |
p. 1721-1733
|
article
|
| 63 |
The optimal time and clinical implications of measurable residual disease detection in mantle cell lymphoma
|
Yan, Yuting
|
|
|
104 |
3 |
p. 1845-1856
|
article
|
| 64 |
Therapy related acute myeloid leukemia secondary to CAR-T therapy in refractory/relapsed multiple myeloma patient showing poor prognosis
|
An, Ran
|
|
|
104 |
3 |
p. 2013-2016
|
article
|
| 65 |
The validation of advanced-stage Hodgkin lymphoma international prognostic index (A-HIPI) in Turkish patients with classical Hodgkin lymphoma
|
Koca, Oguzhan
|
|
|
104 |
3 |
p. 1765-1775
|
article
|
| 66 |
TIGIT/PVR axis regulates anti-tumor immunity in hematologic malignancies
|
Meng, Fanqiao
|
|
|
104 |
3 |
p. 1415-1426
|
article
|
| 67 |
Tirabrutinib for CNS relapsed primary vitreoretinal lymphoma
|
Yoshida, Nao
|
|
|
104 |
3 |
p. 2073-2074
|
article
|
| 68 |
Total psoriasis regression in a patient with chronic myeloid leukemia treated using nilotinib
|
Horňák, Tomáš
|
|
|
104 |
3 |
p. 2001-2004
|
article
|
| 69 |
TP53 deletion is associated with poor survival of adult ALK-positive ALCL patients receiving CHOP-based chemotherapy
|
Katagiri, Seiichiro
|
|
|
104 |
3 |
p. 1801-1806
|
article
|
| 70 |
t(14;22)(q32;q11) translocation involving IGH and IGL acquired at progression of splenic marginal zone lymphoma treated with rituximab, ibrutinib, and obinutuzumab
|
Geyer, Julia T.
|
|
|
104 |
3 |
p. 2005-2011
|
article
|
| 71 |
Treatment patterns and healthcare resource utilization in ruxolitinib-treated patients with myelofibrosis with and without anemia: a real-world analysis
|
Liu, Tom
|
|
|
104 |
3 |
p. 1605-1616
|
article
|
| 72 |
Tumor microenvironment as a novel therapeutic target for lymphoid leukemias
|
Mousavi, Shahrzad
|
|
|
104 |
3 |
p. 1367-1386
|
article
|
| 73 |
Twin pregnancy during treatment with asciminib for chronic myeloid leukemia – a case report
|
Gutierrez de Moraes Pereira, Géssika B. G. M.
|
|
|
104 |
3 |
p. 2051-2054
|
article
|
| 74 |
Unusual peripheral T-cell lymphoma with a cytotoxic phenotype presenting in the pancreas
|
Dubois, Juliette
|
|
|
104 |
3 |
p. 2045-2049
|
article
|
| 75 |
Venetoclax and hypomethylating agents versus tagraxofusp in older patients with blastic plasmacytoid dendritic cell neoplasm
|
Lee, Benjamin J.
|
|
|
104 |
3 |
p. 2069-2071
|
article
|
| 76 |
Visual presentation of age differences in relative survival of hematological neoplasms in Sweden and the neighboring countries
|
Hemminki, Kari
|
|
|
104 |
3 |
p. 1985-1993
|
article
|
| 77 |
When high dose methotrexate stops working, a successful bridge to transplant with TEDDI-R in a case of secondary CNS lymphoma
|
Yiğit Kaya, Süreyya
|
|
|
104 |
3 |
p. 2079-2080
|
article
|
Journal description